PRJ2282/201491: CHESS: CPRD-COPD Hawthorne Effect Study in Salford: A UK cohort study to characterise patients enrolled in the Salford Lung Study and to evaluate a potential Hawthorne effect

First published 06/11/2015

Last updated 23/04/2024

EU PAS number:

EUPAS10376

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

CHESS_Proposal_PRJ2282_FINAL

English (909.57 KB - PDF)View document

Updated protocol

gsk-201491-protocol-redact-v02

First published: 22/02/2024

English (9.9 MB - PDF)View document

Study results

Additional information for 201491

English (92.6 KB - PDF)View document

gsk-201491-clinical-study-report-redact

English (9.44 MB - PDF)View document

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

CoI of investigators

English (375.7 KB - PDF)View document

Composition of steering group and observers

CHESS scientific committee

English (218.17 KB - PDF)View document

PRJ2282/201491: CHESS: CPRD-COPD Hawthorne Effect Study in Salford: A UK cohort study to characterise patients enrolled in the Salford Lung Study and to evaluate a potential Hawthorne effect

Secondary tabs

Share this page